A detailed history of Morgan Stanley transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Morgan Stanley holds 2,545,752 shares of AMRN stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,545,752
Previous 2,563,026 0.67%
Holding current value
$1.12 Million
Previous $1.77 Million 9.33%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.57 - $0.8 $9,846 - $13,819
-17,274 Reduced 0.67%
2,545,752 $1.6 Million
Q2 2024

Oct 17, 2024

SELL
$0.63 - $1.07 $659,792 - $1.12 Million
-1,047,289 Reduced 29.01%
2,563,026 $1.77 Million
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.07 $659,792 - $1.12 Million
-1,047,289 Reduced 29.01%
2,563,026 $1.77 Million
Q1 2024

Oct 17, 2024

BUY
$0.82 - $1.35 $858,776 - $1.41 Million
1,047,289 Added 40.86%
3,610,315 $3.21 Million
Q1 2024

Aug 16, 2024

SELL
$0.82 - $1.35 $1.6 Million - $2.64 Million
-1,952,768 Reduced 35.1%
3,610,315 $3.21 Million
Q1 2024

May 15, 2024

SELL
$0.82 - $1.35 $1.6 Million - $2.64 Million
-1,952,768 Reduced 35.1%
3,610,315 $3.21 Million
Q4 2023

Aug 16, 2024

BUY
$0.66 - $0.91 $1.98 Million - $2.73 Million
3,000,057 Added 117.05%
5,563,083 $4.84 Million
Q4 2023

Feb 13, 2024

SELL
$0.66 - $0.91 $3.36 Million - $4.64 Million
-5,097,382 Reduced 47.82%
5,563,083 $4.84 Million
Q3 2023

Nov 15, 2023

SELL
$0.85 - $1.43 $524,152 - $881,809
-616,650 Reduced 5.47%
10,660,465 $9.81 Million
Q2 2023

Aug 14, 2023

SELL
$1.12 - $1.49 $305,508 - $406,434
-272,775 Reduced 2.36%
11,277,115 $13.4 Million
Q1 2023

May 15, 2023

SELL
$1.19 - $2.19 $12.5 Million - $22.9 Million
-10,478,005 Reduced 47.57%
11,549,890 $17.3 Million
Q4 2022

Feb 14, 2023

BUY
$1.07 - $1.34 $17.5 Million - $21.9 Million
16,373,362 Added 289.56%
22,027,895 $26.7 Million
Q3 2022

Nov 14, 2022

BUY
$1.09 - $1.67 $345,238 - $528,944
316,733 Added 5.93%
5,654,533 $6.16 Million
Q2 2022

Oct 27, 2022

BUY
$1.13 - $3.69 $790,502 - $2.58 Million
699,560 Added 15.08%
5,337,800 $7.95 Million
Q2 2022

Aug 15, 2022

BUY
$1.13 - $3.69 $790,502 - $2.58 Million
699,560 Added 15.08%
5,337,800 $7.95 Million
Q1 2022

Oct 27, 2022

SELL
$2.85 - $3.73 $1.99 Million - $2.61 Million
-699,560 Reduced 13.11%
4,638,240 $15.3 Million
Q1 2022

May 13, 2022

SELL
$2.85 - $3.73 $552,828 - $723,526
-193,975 Reduced 4.01%
4,638,240 $15.3 Million
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $4.87 Million - $7.79 Million
-1,504,191 Reduced 23.74%
4,832,215 $16.3 Million
Q3 2021

Nov 15, 2021

BUY
$3.94 - $5.84 $25 Million - $37 Million
6,336,406 New
6,336,406 $32.3 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.